Ultrasonographic Fetal Nuchal Translucency Measurements and Cytogenetic Outcomes

Question  Is there an association between nuchal translucency measurements less than 3.5 mm and chromosomal anomalies?

Findings  In this population-based cohort study including 414 268 singleton pregnancies in Ontario, Canada, a significantly increased risk of chromosomal anomalies was associated with each increasing level of nuchal translucency measurement, compared with a reference group of pregnancies with nuchal translucencies less than 2.0 mm.

Meaning  The findings of this cohort study suggest that pregnancies with nuchal translucency measurements greater than 2.0 mm are at increased risk of chromosomal anomalies, indicating that the widely used threshold of 3.5 mm may need to be reexamined.

JAMA 7(3):e243689 doi:10.1001/jamanetworkopen.2024.3689.

Back to News Search

Contact Us

Prenatal Screening Ontario 
CHEO Research Institute 
Centre for Practice-Changing Research Building 
401 Smyth Road 
Ottawa, ON K1H 8L1

pso@bornontario.ca

Information line
Phone: 613-737-2281
Toll-Free: 1-833-351-6490

Monday to Friday, 9:00 AM to 3:00 PM EST

Subscribe to PSO Updates

Subscribe to stay informed about the latest PSO news and prenatal screening updates in Ontario.
Virtual educational sessions on prenatal screening and nuchal translucency quality assurance are available upon request for health‑care providers.